{"id":3981,"date":"2024-02-01T15:48:00","date_gmt":"2024-02-01T20:48:00","guid":{"rendered":"https:\/\/stillcoviding.ca\/fr\/?p=3981"},"modified":"2024-02-01T21:19:32","modified_gmt":"2024-02-02T02:19:32","slug":"new-estimates-show-latest-covid-vaccine-cuts-risk-of-symptomatic-infection","status":"publish","type":"post","link":"https:\/\/stillcoviding.ca\/fr\/nouvelles\/new-estimates-show-latest-covid-vaccine-cuts-risk-of-symptomatic-infection\/","title":{"rendered":"New estimates show latest COVID vaccine cuts risk of symptomatic infection"},"content":{"rendered":"<p>Aujourd\u2019hui, dans <i>Morbidity and Mortality Weekly Report<\/i>, les chercheurs ont publi\u00e9 des r\u00e9sultats montrant que les adultes qui ont re\u00e7u un vaccin COVID-19 mis \u00e0 jour pour 2023-2024 \u00e9taient 54&nbsp;% moins susceptibles d\u2019avoir une infection symptomatique que ceux qui ne l\u2019ont pas fait, et le vaccin a \u00e9t\u00e9 trouv\u00e9 pour prot\u00e9ger contre JN.1 et d\u2019autres variants circulants.<\/p>\n<p>C\u2019est l\u2019une des premi\u00e8res \u00e9tudes \u00e0 mettre \u00e0 jour les donn\u00e9es sur l\u2019efficacit\u00e9 du vaccin contre la COVID-19 (EV) en 2023-2024. Le vaccin de rappel monovalent (souche unique) d\u00e9riv\u00e9 de XBB.1.5 a \u00e9t\u00e9 approuv\u00e9 pour utilisation chez tous les Am\u00e9ricains \u00e2g\u00e9s de 6&nbsp;mois et plus le 12&nbsp;septembre\u00a02023, mais le taux de participation a \u00e9t\u00e9 faible. De plus, les souches XBB du virus, sur lesquelles le vaccin \u00e9tait bas\u00e9, ne sont plus les souches dominantes aux \u00c9tats-Unis, ayant \u00e9t\u00e9 remplac\u00e9es par JN.1 en d\u00e9cembre\u00a02023.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aujourd\u2019hui, dans <i>Morbidity and Mortality Weekly Report<\/i>, les chercheurs ont publi\u00e9 des r\u00e9sultats montrant que les adultes qui ont re\u00e7u un vaccin COVID-19 mis \u00e0 jour pour 2023-2024 \u00e9taient 54&nbsp;% moins susceptibles d\u2019avoir une infection symptomatique que ceux qui ne l\u2019ont pas fait, et le vaccin a \u00e9t\u00e9 trouv\u00e9 pour prot\u00e9ger contre JN.1 et d\u2019autres variants circulants.<\/p>\n<p>C\u2019est l\u2019une des premi\u00e8res \u00e9tudes \u00e0 mettre \u00e0 jour les donn\u00e9es sur l\u2019efficacit\u00e9 du vaccin contre la COVID-19 (EV) en 2023-2024. Le vaccin de rappel monovalent (souche unique) d\u00e9riv\u00e9 de XBB.1.5 a \u00e9t\u00e9 approuv\u00e9 pour utilisation chez tous les Am\u00e9ricains \u00e2g\u00e9s de 6&nbsp;mois et plus le 12&nbsp;septembre\u00a02023, mais le taux de participation a \u00e9t\u00e9 faible. De plus, les souches XBB du virus, sur lesquelles le vaccin \u00e9tait bas\u00e9, ne sont plus les souches dominantes aux \u00c9tats-Unis, ayant \u00e9t\u00e9 remplac\u00e9es par JN.1 en d\u00e9cembre\u00a02023.<\/p>\n<div class=\"more-link-wrapper\"><a class=\"more-link\" href=\"https:\/\/stillcoviding.ca\/fr\/nouvelles\/new-estimates-show-latest-covid-vaccine-cuts-risk-of-symptomatic-infection\/\">Lire la suite<span class=\"screen-reader-text\">New estimates show latest COVID vaccine cuts risk of symptomatic infection<\/span><\/a><\/div>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[16,677,7,12,13,45,257],"class_list":["post-3981","post","type-post","status-publish","format-standard","hentry","category-nouvelles","tag-covid-19","tag-jn-1","tag-recherche","tag-sras-cov-2","tag-vaccins","tag-variants","tag-xbb-1-5","entry"],"_links":{"self":[{"href":"https:\/\/stillcoviding.ca\/fr\/wp-json\/wp\/v2\/posts\/3981","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stillcoviding.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stillcoviding.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stillcoviding.ca\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stillcoviding.ca\/fr\/wp-json\/wp\/v2\/comments?post=3981"}],"version-history":[{"count":1,"href":"https:\/\/stillcoviding.ca\/fr\/wp-json\/wp\/v2\/posts\/3981\/revisions"}],"predecessor-version":[{"id":3982,"href":"https:\/\/stillcoviding.ca\/fr\/wp-json\/wp\/v2\/posts\/3981\/revisions\/3982"}],"wp:attachment":[{"href":"https:\/\/stillcoviding.ca\/fr\/wp-json\/wp\/v2\/media?parent=3981"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stillcoviding.ca\/fr\/wp-json\/wp\/v2\/categories?post=3981"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stillcoviding.ca\/fr\/wp-json\/wp\/v2\/tags?post=3981"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}